301122 Caina Technology
- 19.35
- -0.39-1.98%
Caina Technology News
Adopting Co., Ltd. (301122.SZ): "An adjustable needleless infusion connector" has been granted a patent.
On June 14th, Gelunhui reported that Cai Na Shares (301122.SZ) announced that its wholly-owned subsidiary, Jiangsu Cai Na Medical technology Co., LTD. (referred to as "Cai Na Medical"), has recently received a patent certificate issued by the National Intellectual Property Office for an adjustable needle-free infusion connector.
Express News | Caina Corporation: Its wholly-owned subsidiary recently received a patent certificate issued by the National Intellectual Property Office.
Express News | Caina Co., Ltd.: Anna Life Science has completed the industrial and commercial registration procedures.
Express News | Hongxin Jianfa (09930.HK) adopts the stock option plan.
Qingxi Medical (01406) issued 792,100 shares based on the adopted stock incentive plan.
Clear Medical (01406) announced that on June 4, 2024, it will issue bonds in accordance with the authorization granted by the resolution passed on November 23, 2022. ...
Gofintech Innov (00290.HK) adopts stock incentive plan.
On June 3rd, GeLongHui announced that GoFinTech Innovations (00290.HK) has applied and obtained approval from the listing committee to issue and distribute shares for the stock reward plan, which includes relevant content. All conditions for the stock reward plan have been met, and the plan has taken effect on June 3, 2024.
Adopt shares (301122.SZ) to transfer 6.36% of Zhenhong Heavy Industries
Adoption Shares (301122.SZ) issued an announcement, and the company held the 3rd term of directors on May 31, 2024...
Express News | Adoption of shares: It is proposed to use 40 million yuan of its own capital to participate in Zhenhong Heavy Industries through share transfer. After completing the transfer, the company will hold 5 million shares of Zhenhong Heavy Industries' shares, ac
Express News | Adoption of shares: The wholly-owned subsidiary obtained 2 utility model patent certificates
Zhixing Automotive Technology (01274.HK): Proposed adoption of a share award scheme
On May 23, Gelonghui | Zhixing Auto Technology (01274.HK) issued an announcement. On May 23, 2024, the board of directors resolved to recommend the adoption of the Company's H share award plan.
Express News | The concept of assisted reproduction is highly open, and Dajia Weikang is over 10%
Laikai Pharmaceutical-B (02105.HK) proposes to adopt a share award scheme
Gelonghui, May 21丨Laikai Pharmaceutical-B (02105.HK) announced that the board of directors has resolved to approve the proposed adoption of the share award plan, subject to shareholders' approval at the annual shareholders' meeting. The purpose of the share award scheme is to attract and retain participants who have contributed significantly to the long-term growth and success of the Group, recognize and reward their past contributions to the Group, provide participants with an opportunity to obtain the company's exclusive rights and encourage participants to further contribute to the company, and strive to enhance the value of the company and its shares to meet the overall interests of the company and its shareholders. The share award program provides companies with a flexible approach to
Adopted shares (301122.SZ): 2023 equity distribution, 10 distributions of 4 yuan, share registration date May 20
On May 13, Ge Longhui announced the adoption of shares (301122.SZ). The company's 2023 equity distribution plan is to distribute RMB 4.000000 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 122,245,658 shares. The share registration date for this equity distribution is May 20, 2024, and the ex-dividend date is May 21, 2024.
Express News | Adoption of shares: Investment in the establishment of a wholly-owned subsidiary Warner Healthcare
Adoption of shares (301122.SZ): Proposed establishment of an overseas holding subsidiary
Gelonghui, May 10 | Adoption of shares (301122.SZ) announced that the company plans to adopt CMTINVESTMENT (SINGAPORE) PTE.LTD, a wholly-owned subsidiary in Singapore. (“CMT Investment”) is the investor and established a joint venture CMTINDUSTRY (SINGAPORE) PTE.LTD in Singapore with RIXTRONMEDICALTRADINGCO.L.L.C. (“CMT Industrial” for short) and established the company Camedical in Cambodia through the joint venture CMT Industrial
Express News | Adoption of shares: Proposed foreign investment to establish a Cambodian company as an overseas holding subsidiary
Huanlong Holdings (02260) adopts share award scheme
Huanlong Holdings (02260) issued an announcement. The company adopted a share award plan on May 9, 2024, and the directors...
Guangshang Culture Holdings (08082): Approval of the share award scheme
According to Zhitong Finance App News, Guangshang Culture Holdings (08082) issued an announcement. According to the voting results of the special shareholders' meeting and section 23.02 (1) of the GEM listing rules, ordinary resolutions approving the adoption of the share award plan; and terminating the current share option plan and adopting a new share option plan were officially passed by voting.
Adopted shares (301122.SZ): Net profit of 2,5454 million yuan in the first quarter increased 57.73% year-on-year
On April 24, Ge Longhui shares (301122.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 111 million yuan, up 65.52% year on year; net profit attributable to shareholders of listed companies was 25.454 million yuan, up 57.73% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 177.03.98 million yuan, up 114.87% year on year; basic earnings per share were 0.20 yuan.
Open Source Securities released a research report on April 19 stating that it gave the adopted shares (301122.SZ) a purchase rating. The main reasons for the rating include: 1) the size of the injection/puncture market is growing steadily, and overseas ex
Open Source Securities released a research report on April 19 stating that it gave the adopted shares (301122.SZ) a purchase rating. The main reasons for the rating include: 1) the size of the injection/puncture market is growing steadily, and overseas export pressure urgently needs to be resolved; 2) the medical+vettic+laboratory consumables troika, which drives rapid growth in performance due to technology+category+production capacity. (Mainichi Keizai Shimbun)
Analysis
Price Target
No Data
